Proteins associated with the physiopathology and biology of breast cancer, such as estrogen, p53, HER2, Ki-67, VEGF, progesterone, and EGFRs, represent specific molecular targets for molecular MRI of breast cancers (Figure 2) [36–38]. This evidence concerns the gene ERBB2 and breast carcinoma.